The Food and Drug Administration recently finalized the last of 32 OTC monographs as required in 2020 legislation overhauling its program which makes the large majority of nonprescription drugs available in the US.
Some industry stakeholders, though, might not know the agency has started the overhaul.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?